Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.60
Delayed Data
As of Feb 24
 +0.05 / +0.90%
Today’s Change
3.80
Today|||52-Week Range
6.90
+2.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$142.6M

Company Description

CytoSorbents Corp. is a critical care immunotherapy company, which engages in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Its products include cytosorb, contrastsorb, vetresq, hemodefend, and drugsorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885825

Employees

Shareholders

Other institutional3.33%
Individual stakeholders25.19%
Mutual fund holders2.93%

Top Executives

Phillip P. ChanPresident, Chief Executive Officer & Director
Vincent CapponiChief Operating Officer
Kathleen P. BlochCFO, Secretary & Principal Accounting Officer
Robert Hawes BartlettChief Medical Officer
Steven SiskDirector-Clinical Operations